Hierarchical Porous Silica Particles for Nutrient Absorption Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for prediabetes and type 2 diabetes are inadequate, with lifestyle interventions having low compliance and existing medications causing side effects, while porous silica particles have shown potential for reducing body weight but not directly targeting lipid and blood glucose levels.

Innovation Solution

Development of highly structured porous silica particles with specific pore sizes and distributions, acting as molecular sieves to directly target carbohydrate and lipid homeostasis, providing a novel treatment for metabolic disorders.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If lifestyle intervention is used for prediabetes management, then patient compliance is improved, but treatment effectiveness is worsened due to low compliance rate

Engineering Contradiction:
Improvepatient complianceVSAvoidtreatment effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The porous silica particles provide autonomous therapeutic action by physically interfering with nutrient absorption in the digestive system. The particles automatically reduce carbohydrate and lipid uptake without requiring patient behavior change or compliance, thereby eliminating the compliance-effectiveness trade-off inherent in lifestyle interventions.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention replaces the mechanical/lifestyle-based intervention system with a physical-chemical system. The porous silica particles use their unique pore structure and surface properties to passively block nutrient absorption, substituting the need for mechanical lifestyle changes with a physical barrier mechanism that operates independently of patient compliance.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If existing medications are used for metabolic disorders, then treatment effectiveness is improved, but harmful factors are worsened due to side effects

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention converts the passive observation of silica particles in the digestive system into a beneficial therapeutic effect. By utilizing the natural presence of silica in food and water and demonstrating its ability to reduce nutrient absorption, the invention transforms a neutral observation into a beneficial mechanism for treating metabolic disorders without the harmful side effects of conventional medications.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention employs porous silica particles with specific pore size distributions (including mesopores of 2-50 nm and micropores of 0.3-2 nm) to physically interfere with nutrient absorption. The porous structure provides a large surface area and selective permeability that blocks carbohydrate-digesting enzymes and lipid absorption, achieving therapeutic effects through physical exclusion rather than chemical action, thereby avoiding medication side effects.

Inventive Principle:
Principle #31Porous materials

3Weight of moving object

If porous silica particles are used to reduce body weight, then weight loss is improved, but treatment specificity is worsened as it does not directly target lipid and blood glucose levels

Engineering Contradiction:
Improvebody weightVSAvoidtreatment specificity
Core Design Contradiction:
Weight of moving objectVSAdaptability or versatility

Solution Approach 1:

The invention applies local quality by creating different pore size distributions within the silica particle structure. The particles contain both mesopores (2-50 nm) for general nutrient interaction and micropores (0.3-2 nm) for selective enzyme trapping. This hierarchical pore structure provides localized functional zones that specifically target carbohydrate-digesting enzymes and lipid absorption pathways, enabling simultaneous weight loss and specific metabolic parameter control.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention utilizes parameter changes by precisely controlling the pore size distribution parameters of the silica particles. By adjusting the ratio and dimensions of mesopores and micropores, the particles can be optimized to target specific metabolic pathways. The patent describes particles with specific pore size ratios and distributions that enhance selective interaction with digestive enzymes and nutrients, thereby achieving both weight reduction and specific metabolic benefits.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The silica particles effectively manage metabolic disorders by controlling pore size and distribution, offering a safer and more efficient alternative to existing treatments for prediabetes and type 2 diabetes.

Implementation Method 1

acting as molecular sieves to directly target carbohydrate and lipid homeostasis

Methodology Applied
Scientific EffectMolecular sieve: Molecular Sieve

Implementation Method 2

The silica particles effectively manage metabolic disorders by controlling pore size and distribution

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS12492129B2Highly structured porous silica materials and biological uses thereof
Publication Date: 2025.12.09 SIGRID THERAPEUTICS
  • US12492129B2 patent drawing
  • US12492129B2 patent drawing
  • US12492129B2 patent drawing

AI summary

There is provided herein a porous silica particle characterized by having a hierarchical pore structure wherein at least about 20% of the pores of the silica particle are of a size in the range of from about 7.0 to about 13.0 nm, and at least about 10% of the pores of the silica particle are of a size in the range of from about 0.5 to about 5.0 nm, and by having a particle size of from about 0.1 μm to about 10.0 μm. There is also provided compositions comprising such silica particles, process for their preparation, and medical and non-medical uses thereof.